HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of systemic vasculitis with cyclophosphamide and steroids: daily oral low-dose cyclophosphamide administration after failure of a pulse intravenous high-dose regimen in four patients.

Abstract
The efficacy of cyclophosphamide (CY) in the treatment of severe systemic vasculitis has been demonstrated, but its optimal administration regimen remains to be defined. The four patients described participated in prospective therapeutic trials of polyarteritis nodosa (PAN) without hepatitis B infection markers, Churg-Strauss syndrome (CSS) and Wegener's granulomatosis (WG) and received daily oral low-dose CY after failure of a monthly pulse regimen. These patients were included in this study because of failure to induce clinical remission (two patients) and relapse during the course of treatment (two patients). The results were good with initial clinical remission in three patients and stabilization in one. One patient with WG relapsed 10 months after changing therapeutics. The advantages of the different administration protocols are discussed.
AuthorsT Généreau, O Lortholary, P Leclerq, D Grenet, M Tubéry, D Sicard, I Caubarrère, L Guillevin
JournalBritish journal of rheumatology (Br J Rheumatol) Vol. 33 Issue 10 Pg. 959-62 (Oct 1994) ISSN: 0263-7103 [Print] England
PMID7921758 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Steroids
  • Cyclophosphamide
Topics
  • Administration, Oral
  • Aged
  • Churg-Strauss Syndrome (drug therapy)
  • Cyclophosphamide (administration & dosage)
  • Drug Administration Schedule
  • Female
  • Granulomatosis with Polyangiitis (drug therapy)
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Polyarteritis Nodosa (drug therapy)
  • Prospective Studies
  • Steroids (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: